Deutsche Bank
DTIL icon

Deutsche Bank’s Precision BioSciences DTIL Stock Holding History

Deutsche Bank’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
+23,408
New +$165K ﹤0.01% 3303
2023
Q1 		– Sell
-3,949
Closed -$141K – 3932
2022
Q4 		$141K Hold
3,949
– – ﹤0.01% 3157
2022
Q3 		$154K Buy
3,949
+18
+0.5% +$855 ﹤0.01% 3093
2022
Q2 		$189K Sell
3,931
-2,349
-37% -$138K ﹤0.01% 3210
2022
Q1 		$580K Sell
6,280
-157
-2% -$21.3K ﹤0.01% 2658
2021
Q4 		$1.43M Buy
6,437
+4,042
+169% +$1.13M ﹤0.01% 2217
2021
Q3 		$829K Sell
2,395
-493
-17% -$167K ﹤0.01% 2733
2021
Q2 		$1.08M Buy
2,888
+879
+44% +$264K ﹤0.01% 2711
2021
Q1 		$623K Buy
2,009
+297
+17% +$104K ﹤0.01% 2965
2020
Q4 		$429K Buy
1,712
+844
+97% +$207K ﹤0.01% 3007
2020
Q3 		$160K Buy
868
+73
+9% +$14.5K ﹤0.01% 3327
2020
Q2 		$199K Buy
795
+376
+90% +$82.3K ﹤0.01% 3147
2020
Q1 		$76K Sell
419
-24
-5% -$6.28K ﹤0.01% 3360
2019
Q4 		$184K Buy
443
+357
+415% +$112K ﹤0.01% 3277
2019
Q3 		$20K Sell
86
-308
-78% -$100K ﹤0.01% 4317
2019
Q2 		$156K Buy
+394
New +$159K ﹤0.01% 3971

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Deutsche Bank's DTIL Position: Q2 2026 in Review

Deutsche Bank opened a new position in Precision BioSciences (DTIL) in Q2 2026: 23,408 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #3303 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in DTIL as recently as Q4 2022.

Deutsche Bank first reported a position in DTIL in Q2 2019 and has held it in 16 quarters since. The position peaked at $1.43M in Q4 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Deutsche Bank held 23,408 shares of Precision BioSciences worth $184K as of Q2 2026.
  • Precision BioSciences was a new Deutsche Bank position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3303 holding.
  • Deutsche Bank first reported a position in Precision BioSciences in Q2 2019 and has held it in 16 quarters since.
  • Deutsche Bank's Precision BioSciences position peaked at $1.43M in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.